Importantly, our data supports the evidence that SATB1 is associated with better OS in HR-positive breast cancer (although did not reach statistical significance as a single predictor, p = 0.07), especially, when co-expressed with and HIF-1α (factor 2). Here, HIF1A is linked to breast carcinoma.